A male patient, aged 42, presents to his primary care provider with a 3-month history of e… — USMLE Step 3

A male patient, aged $42$ , presents to his primary care provider with a $3$ -month history of excessive urination and an unquenchable thirst, requiring him to consume over $5$ liters of water daily. He has a $10$ -year history of bipolar I disorder, which has been well-controlled on lithium carbonate. Two prior attempts by his psychiatrist to taper the lithium and transition to alternative mood stabilizers resulted in severe manic episodes requiring involuntary inpatient hospitalizations. His current blood pressure is $118/76\text{ mmHg}$ and heart rate is $82\text{/min}$ . Laboratory evaluation reveals:

Serum sodium: $146\text{ mEq/L}$
Serum potassium: $4.1\text{ mEq/L}$
Serum creatinine: $1.0\text{ mg/dL}$
Serum lithium: $0.8\text{ mEq/L}$ (therapeutic range: $0.6-1.2\text{ mEq/L}$ )
Urine specific gravity: $1.003$
Urine osmolality: $140\text{ mOsm/kg H}_2\text{O}$

During the evaluation, the administration of exogenous desmopressin results in a repeat urine osmolality of $145\text{ mOsm/kg H}_2\text{O}$ .

Which of the following is the most appropriate next step in the management of this patient's polyuria?

Initiate therapy with amilorideCevap
B
Initiate therapy with hydrochlorothiazide
C
Discontinue lithium and begin valproate
D
Prescribe intranasal desmopressin
E
Institute oral fluid restriction to under 1.5 liters daily

Cevap

Initiate therapy with amiloride.

The correct intervention is to initiate amiloride. This patient has developed nephrogenic diabetes insipidus (NDI) as an adverse effect of chronic lithium therapy, confirmed by polyuria, inappropriately dilute urine, and a lack of response to exogenous desmopressin. Lithium enters the principal cells of the collecting duct through the epithelial sodium channel (ENaC) and disrupts the antidiuretic hormone (ADH) signaling pathway, preventing the insertion of aquaporin-2 water channels. Because this patient has a history of severe manic episodes when lithium is stopped, discontinuing it carries an unacceptably high risk. Amiloride is a potassium-sparing diuretic that directly blocks ENaC, preventing lithium from entering the principal cells. This partially restores the cell's responsiveness to ADH and mitigates the polyuria while allowing the patient to remain on their life-saving psychiatric medication.

Adım Adım Çözüm

Analyze the clinical presentation and initial laboratory findings.

The patient exhibits polyuria, polydipsia, hypernatremia (high-normal sodium), and dilute urine (low osmolality), which points to diabetes insipidus.

Establishing the clinical syndrome is the first step in formulating a differential diagnosis.

Interpret the results of the desmopressin challenge test.

Urine osmolality remained low (

145\text{ mOsm/kg H}_2\text{O}

) after exogenous desmopressin administration.

A lack of response to exogenous antidiuretic hormone (ADH) differentiates nephrogenic diabetes insipidus (NDI) from central diabetes insipidus.

Identify the etiology of the NDI and assess the risks of altering current maintenance therapies.

The etiology is lithium toxicity. However, the patient has a severe contraindication to stopping lithium (history of severe manic relapses).

Treatment of drug-induced adverse effects must balance the severity of the side effect against the risk of underlying disease relapse.

Select the optimal pharmacologic intervention that treats the side effect while allowing continuation of the necessary mood stabilizer.

Amiloride is selected to manage the NDI.

Amiloride blocks lithium entry into the collecting duct cells, specifically targeting the pathophysiology of lithium-induced NDI without altering systemic lithium clearance or requiring its discontinuation.

Anahtar Kavram

Management of lithium-induced nephrogenic diabetes insipidus in patients who cannot tolerate lithium discontinuation requires the addition of amiloride.

Tahmini Süre:2m 0s

Soru

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Konular

Bu konudan daha fazla soru